Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Historia
27
Filosofía
14
Libre albedrío y determinismo
10
Jazz
9
Música popular
9
Aspectos económicos
8
Sociología
8
Etnología
7
Comercio
6
Aspectos psicológicos
5
Aspectos sociales
5
Cambio social
5
Ciudades y pueblos
5
Libre comercio
5
Modelos matemáticos
5
Política económica
5
Política gubernamental
5
Abuso de drogas
4
Administración
4
Ciencias sociales
4
Condiciones sociales
4
Democracia
4
Educación
4
Filosofía de la mente
4
History
4
Inglés
4
Mercadotecnia
4
Política y gobierno
4
Sistemas operativos (Computadoras)
4
Urbanismo
4
-
485421por Dearnaley, David, Syndikus, Isabel, Mossop, Helen, Khoo, Vincent, Birtle, Alison, Bloomfield, David, Graham, John, Kirkbride, Peter, Logue, John, Malik, Zafar, Money-Kyrle, Julian, O'Sullivan, Joe M, Panades, Miguel, Parker, Chris, Patterson, Helen, Scrase, Christopher, Staffurth, John, Stockdale, Andrew, Tremlett, Jean, Bidmead, Margaret, Mayles, Helen, Naismith, Olivia, South, Chris, Gao, Annie, Cruickshank, Clare, Hassan, Shama, Pugh, Julia, Griffin, Clare, Hall, Emma“…The proportion of patients who were biochemical or clinical failure free at 5 years was 88·3% (95% CI 86·0–90·2) in the 74 Gy group, 90·6% (88·5–92·3) in the 60 Gy group, and 85·9% (83·4–88·0) in the 57 Gy group. 60 Gy was non-inferior to 74 Gy (HR 0·84 [90% CI 0·68–1·03], p(NI)=0·0018) but non-inferiority could not be claimed for 57 Gy compared with 74 Gy (HR 1·20 [0·99–1·46], p(NI)=0·48). …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485422por Horne, Hisani N., Chung, Charles C., Zhang, Han, Yu, Kai, Prokunina-Olsson, Ludmila, Michailidou, Kyriaki, Bolla, Manjeet K., Wang, Qin, Dennis, Joe, Hopper, John L., Southey, Melissa C., Schmidt, Marjanka K., Broeks, Annegien, Muir, Kenneth, Lophatananon, Artitaya, Fasching, Peter A., Beckmann, Matthias W., Fletcher, Olivia, Johnson, Nichola, Sawyer, Elinor J., Tomlinson, Ian, Burwinkel, Barbara, Marme, Frederik, Guénel, Pascal, Truong, Thérèse, Bojesen, Stig E., Flyger, Henrik, Benitez, Javier, González-Neira, Anna, Anton-Culver, Hoda, Neuhausen, Susan L., Brenner, Hermann, Arndt, Volker, Meindl, Alfons, Schmutzler, Rita K., Brauch, Hiltrud, Hamann, Ute, Nevanlinna, Heli, Khan, Sofia, Matsuo, Keitaro, Iwata, Hiroji, Dörk, Thilo, Bogdanova, Natalia V., Lindblom, Annika, Margolin, Sara, Mannermaa, Arto, Kosma, Veli-Matti, Chenevix-Trench, Georgia, Wu, Anna H., ven den Berg, David, Smeets, Ann, Zhao, Hui, Chang-Claude, Jenny, Rudolph, Anja, Radice, Paolo, Barile, Monica, Couch, Fergus J., Vachon, Celine, Giles, Graham G., Milne, Roger L., Haiman, Christopher A., Marchand, Loic Le, Goldberg, Mark S., Teo, Soo H., Taib, Nur A. M., Kristensen, Vessela, Borresen-Dale, Anne-Lise, Zheng, Wei, Shrubsole, Martha, Winqvist, Robert, Jukkola-Vuorinen, Arja, Andrulis, Irene L., Knight, Julia A., Devilee, Peter, Seynaeve, Caroline, García-Closas, Montserrat, Czene, Kamila, Darabi, Hatef, Hollestelle, Antoinette, Martens, John W. M., Li, Jingmei, Lu, Wei, Shu, Xiao-Ou, Cox, Angela, Cross, Simon S., Blot, William, Cai, Qiuyin, Shah, Mitul, Luccarini, Craig, Baynes, Caroline, Harrington, Patricia, Kang, Daehee, Choi, Ji-Yeob, Hartman, Mikael, Chia, Kee Seng, Kabisch, Maria, Torres, Diana, Jakubowska, Anna, Lubinski, Jan, Sangrajrang, Suleeporn, Brennan, Paul, Slager, Susan, Yannoukakos, Drakoulis, Shen, Chen-Yang, Hou, Ming-Feng, Swerdlow, Anthony, Orr, Nick, Simard, Jacques, Hall, Per, Pharoah, Paul D. P., Easton, Douglas F., Chanock, Stephen J., Dunning, Alison M., Figueroa, Jonine D.Enlace del recurso
Publicado 2016
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485423por Stavridi, Flora, Kalogeras, Konstantine T., Pliarchopoulou, Kyriaki, Wirtz, Ralph M., Alexopoulou, Zoi, Zagouri, Flora, Veltrup, Elke, Timotheadou, Eleni, Gogas, Helen, Koutras, Angelos, Lazaridis, Georgios, Christodoulou, Christos, Pentheroudakis, George, Laskarakis, Apostolos, Arapantoni-Dadioti, Petroula, Batistatou, Anna, Sotiropoulou, Maria, Aravantinos, Gerasimos, Papakostas, Pavlos, Kosmidis, Paris, Pectasides, Dimitrios, Fountzilas, George“…RESULTS: The optimal RRS, in terms of disease-free survival (DFS) and overall survival (OS), was based on the co-expression of two of the three evaluated genes (RACGAP1 and TOP2A). …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485424por Diao, H., Yan, H. L., Xiao, Y., Yu, B., Yu, J., He, J., Zheng, P., Zeng, B.H., Wei, H., Mao, X.B., Chen, D.W.“…A total of 24 1-day-old germ-free BALB/C mice were divided into 3 groups (TFM, YFM and RFM), which were transplanted with intact fecal microbiota of Tibetan pig (TP), Yorkshire pig (YP) and Rongchang pig (RP), respectively. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485425por Kapural, Leonardo, Yu, Cong, Doust, Matthew W., Gliner, Bradford E., Vallejo, Ricardo, Sitzman, B. Todd, Amirdelfan, Kasra, Morgan, Donna M., Yearwood, Thomas L., Bundschu, Richard, Yang, Thomas, Benyamin, Ramsin, Burgher, Abram H.“…In comparison, 10-kHz high-frequency (HF10 therapy) SCS therapy does not rely on intraoperative paresthesia mapping and remains paresthesia-free during therapy. OBJECTIVE: To compare long-term results of HF10 therapy and traditional low-frequency SCS. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485426por Zong, Geng, Li, Yanping, Wanders, Anne J, Alssema, Marjan, Zock, Peter L, Willett, Walter C, Hu, Frank B, Sun, Qi“…Participants 73 147 women in the Nurses’ Health Study (1984-2012) and 42 635 men in the Health Professionals Follow-up Study (1986-2010), who were free of major chronic diseases at baseline. Main outcome measure Incidence of coronary heart disease (n=7035) was self-reported, and related deaths were identified by searching National Death Index or through report of next of kin or postal authority. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485427por DeVries, Aaron, Talley, Pamela, Sweet, Kristin, Kline, Susan, Stinchfield, Patricia, Tosh, Pritish, Danila, RichardEnlace del recurso
Publicado 2016
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485428por Zhang, Yu, He, Rong-quan, Dang, Yi-wu, Zhang, Xiu-ling, Wang, Xiao, Huang, Su-ning, Huang, Wen-ting, Jiang, Meng-tong, Gan, Xiao-ning, Xie, You, Li, Ping, Luo, Dian-zhong, Chen, Gang, Gan, Ting-qing“…In addition, RSPO3, ADAMTS8 and DOCK8 were related to overall survival and disease-free survival (all P < 0.05) of lung adenocarcinoma patients in TCGA. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485429por Neal, Joel W., Dahlberg, Suzanne E., Wakelee, Heather A., Aisner, Seena C., Bowden, Michaela, Huang, Ying, Carbone, David P., Gerstner, Gregory J., Lerner, Rachel E., Rubin, Jerome L., Owonikoko, Taofeek K., Stella, Philip J., Steen, Preston D., Khalid, Ahmed Ali, Ramalingam, Suresh S.“…METHODS: In this three arm, randomised phase 2 study, the primary endpoint was to compare progression-free survival (PFS) of patients treated with cabozantinib versus erlotinib alone, and the combination of erlotinib plus cabozantinib versus erlotinib alone. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485430The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomaspor Palmerini, Emanuela, Colangeli, Marco, Nanni, Cristina, Fanti, Stefano, Marchesi, Emanuela, Paioli, Anna, Picci, Piero, Cambioli, Silvia, Donati, Davide, Cevolani, Luca, De Paolis, Massimiliano, Gambarotti, Marco, Ferrari, Stefano“…A good histological response was achieved in 53 % of EWS patients, and 41 % of OS patients. The 3-year event-free survival (EFS) was 57 % in EWS patients and 48 % OS patients. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485431“…This study aimed to (1) assess the PROs (health-related quality of life (HRQoL), mental health and perceived social support) of HCV patients receiving DAAs therapy prior, during and at the end of therapy; (2) evaluate PROs of Interferon-free (dual) users versus Interferon-containing (triple) users cross the three different time periods; and (3) identify the predictors of HRQoL of DAAs therapy users cross the three different time periods. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485432por Geddes, Rastafa I., Hayashi, Kentaro, Bongers, Quinn, Wehber, Marlyse, Anderson, Icelle M., Jansen, Alex D., Nier, Chase, Fares, Emily, Farquhar, Gabrielle, Kapoor, Amita, Ziegler, Toni E., VadakkadathMeethal, Sivan, Bird, Ian M., Atwood, Craig S.Enlace del recurso
Publicado 2017
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485433
-
485434por Virdee, Pradeep S, Moschandreas, Joanna, Gebski, Val, Love, Sharon B, Francis, E Anne, Wasan, Harpreet S, van Hazel, Guy, Gibbs, Peter, Sharma, Ricky A“…Secondary outcome measures include progression-free survival (PFS), liver-specific PFS, health-related quality of life, response rate, resection rate, and adverse event profile. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485435por Chaib, Imane, Karachaliou, Niki, Pilotto, Sara, Codony Servat, Jordi, Cai, Xueting, Li, Xuefei, Drozdowskyj, Ana, Servat, Carles Codony, Yang, Jie, Hu, Chunping, Cardona, Andres Felipe, Vivanco, Guillermo Lopez, Vergnenegre, Alain, Sanchez, Jose Miguel, Provencio, Mariano, Reguart, Noemi, Zhou, Caicun, Cao, Peng, Ma, Patrick C., Bivona, Trever G., Rosell, Rafael, Chaib, Imane, Karachaliou, Niki, Pilotto, Sara, Servat, Jordi Codony, Cai, Xueting, Li, Xuefei, Drozdowskyj, Ana, Servat, Carles Codony, Yang, Jie, Hu, Chunping, Cardona, Andres Felipe, Vivanco, Guillermo Lopez, Vergnenegre, Alain, Sanchez, Jose Miguel, Provencio, Mariano, de Marinis, Filippo, Passaro, Antonio, Carcereny, Enric, Reguart, Noemi, Campelo, Charo Garcia, Teixido, Cristina, Sperduti, Isabella, Rodriguez, Sonia, Lazzari, Chiara, Verlicchi, Alberto, de Aguirre, Itziar, Queralt, Cristina, Wei, Jia, Estrada, Roger, de la Bellacasa, Raimon Puig, Ramirez, Jose Luis, Jacobsen, Kirstine, Ditzel, Henrik J., Santarpia, Mariacarmela, Viteri, Santiago, Molina, Miguel Angel, Zhou, Caicun, Cao, Peng, Ma, Patrick C., Bivona, Trever G., Rosell, Rafael“…High expression of STAT3 or YAP1 predicted worse progression-free survival (hazard ratio [HR] = 3.02, 95% CI = 1.54 to 5.93, P = .001, and HR = 2.57, 95% CI = 1.30 to 5.09, P = .007, respectively) in an initial cohort of 64 EGFR-mutant NSCLC patients treated with firstline EGFR TKIs. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485436por Dellicour, Stephanie, Sevene, Esperança, McGready, Rose, Tinto, Halidou, Mosha, Dominic, Manyando, Christine, Rulisa, Stephen, Desai, Meghna, Ouma, Peter, Oneko, Martina, Vala, Anifa, Rupérez, Maria, Macete, Eusébio, Menéndez, Clara, Nakanabo-Diallo, Seydou, Kazienga, Adama, Valéa, Innocent, Calip, Gregory, Augusto, Orvalho, Genton, Blaise, Njunju, Eric M., Moore, Kerryn A., d’Alessandro, Umberto, Nosten, Francois, ter Kuile, Feiko, Stergachis, AndyEnlace del recurso
Publicado 2017
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485437“…The 24-h urine protein levels in the PI and EP subgroups of the L-NA+RA group were significantly lower compared with the respective levels in the L-NA+C groups (1037 ± 63 vs. 2127 ± 593 μg; 976 ± 42 vs. 1238 ± 72 μg; both P < 0.05), also this effect appeared similar in the PI and EP subgroups of the LPS+RA and LPS+C groups (1022 ± 246 vs. 2141 ± 432 μg; 951 ± 41 vs. 1308 ± 30 μg; both P < 0.05). The levels of serum-free fatty acid (FFA) in the PI and EP subgroups of the L-NA+RA groups were significantly lower compared with the respective levels in the L-NA+C group (2.49 ± 0.44 vs. 3.30 ± 0.18 mEq/L; 2.23 ± 0.29 vs. 2.84 ± 0.14 mEq/L; both P < 0.05). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485438por Abreha, Tesfay, Hwang, Jimee, Thriemer, Kamala, Tadesse, Yehualashet, Girma, Samuel, Melaku, Zenebe, Assef, Ashenafi, Kassa, Moges, Chatfield, Mark D., Landman, Keren Z., Chenet, Stella M., Lucchi, Naomi W., Udhayakumar, Venkatachalam, Zhou, Zhiyong, Shi, Ya Ping, Kachur, S. Patrick, Jima, Daddi, Kebede, Amha, Solomon, Hiwot, Mekasha, Addis, Alemayehu, Bereket Hailegiorgis, Malone, Joseph L., Dissanayake, Gunewardena, Teka, Hiwot, Auburn, Sarah, von Seidlein, Lorenz, Price, Ric N.Enlace del recurso
Publicado 2017
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485439por McGinnity, Colm J., Riaño Barros, Daniela A., Rosso, Lula, Veronese, Mattia, Rizzo, Gaia, Bertoldo, Alessandra, Hinz, Rainer, Turkheimer, Federico E., Koepp, Matthias J., Hammers, Alexander“…We quantified regional binding using six methods (12 variants), some of which were region-based (applied to the average time-activity curve within a region) and others were voxel-based: 1) Models requiring arterial ppIFs – regional reversible compartmental models with one and two tissue compartments (2kbv and 4kbv); 2) Regional and voxelwise Logan’s graphical analyses (Logan et al., 1990), which required arterial ppIFs; 3) Model-free regional and voxelwise (exponential) spectral analyses (SA; (Cunningham and Jones, 1993)), which also required arterial ppIFs; 4) methods not requiring arterial ppIFs – voxelwise standardised uptake values (Kenney et al., 1941), and regional and voxelwise simplified reference tissue models (SRTM/SRTM2) using brainstem or alternatively cerebellum as pseudo-reference regions (Lammertsma and Hume, 1996; Gunn et al., 1997). …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485440por Snyder, Alexandra, Nathanson, Tavi, Funt, Samuel A., Ahuja, Arun, Buros Novik, Jacqueline, Hellmann, Matthew D., Chang, Eliza, Aksoy, Bulent Arman, Al-Ahmadie, Hikmat, Yusko, Erik, Vignali, Marissa, Benzeno, Sharon, Boyd, Mariel, Moran, Meredith, Iyer, Gopa, Robins, Harlan S., Mardis, Elaine R., Merghoub, Taha, Hammerbacher, Jeff, Rosenberg, Jonathan E., Bajorin, Dean F.“…These parameters were assessed for correlation with DCB (defined as progression-free survival [PFS] >6 months), PFS, and overall survival (OS), both alone and in the context of clinical and intratumoral parameters known to be predictive of survival in this disease state. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto